Daniela Angst

Title: Daniela Angst: Innovator in Pharmaceutical Chemistry

Introduction

Daniela Angst is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for the treatment of various diseases. With a total of six patents to her name, her work has the potential to impact the medical community significantly.

Latest Patents

Among her latest patents, Daniela has developed hydroquinazoline derivatives aimed at treating specific diseases or disorders. This patent discloses a compound of Formula (I) or a pharmaceutically acceptable salt thereof, with specific structural components described in detail. Additionally, she has introduced amino pyrimidine derivatives, which are new compounds that interact with Bruton's tyrosine kinase (Btk). These novel amino pyrimidines may be effective in treating autoimmune disorders, inflammatory diseases, allergic diseases, and various cancers, including those of hematopoietic origin or solid tumors.

Career Highlights

Throughout her career, Daniela has worked with notable organizations such as Novartis AG and the University of Pennsylvania. Her experience in these prestigious institutions has allowed her to refine her research skills and contribute to groundbreaking innovations in the pharmaceutical industry.

Collaborations

Daniela has collaborated with esteemed colleagues, including Anna Vulpetti and Francois Gessier. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

In summary, Daniela Angst is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments for various diseases. Her innovative patents and collaborations highlight her commitment to advancing medical science.